A share price of Rocket Pharmaceuticals Inc [RCKT] is currently trading at $6.59, down -3.80%. An important factor to consider is whether the stock is rising or falling in short-term value. The RCKT shares have gain 8.84% over the last week, with a monthly amount drifted -5.45%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rocket Pharmaceuticals Inc [NASDAQ: RCKT] stock has seen the most recent analyst activity on March 12, 2025, when BMO Capital Markets initiated its Outperform rating and assigned the stock a price target of $50. Previously, Wedbush started tracking the stock with Outperform rating on December 30, 2024, and set its price target to $32. On December 18, 2024, Jefferies initiated with a Buy rating and assigned a price target of $29 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating. Goldman initiated its recommendation with a Neutral and recommended $39 as its price target on April 02, 2024. Cantor Fitzgerald started tracking with a Overweight rating for this stock on October 24, 2023, and assigned it a price target of $65. In a note dated February 01, 2023, Morgan Stanley initiated an Overweight rating and provided a target price of $45 on this stock.
Rocket Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $4.55 and $26.98. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Rocket Pharmaceuticals Inc [NASDAQ: RCKT] shares were valued at $6.59 at the most recent close of the market. An investor can expect a potential return of 385.58% based on the average RCKT price forecast.
Analyzing the RCKT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.65 and Total Capital is -0.62. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rocket Pharmaceuticals Inc [NASDAQ:RCKT] is 9.19. On the other hand, the Quick Ratio is 9.19, and the Cash Ratio is 1.41.
Transactions by insiders
Recent insider trading involved Militello John,, that happened on May 16 ’25 when 655.0 shares were sold., Patel Kinnari completed a deal on May 16 ’25 to sell 1409.0 shares. Meanwhile, Schwartz Jonathan David sold 1582.0 shares on May 16 ’25.
